When the ongoing COVID pandemic first erupted in early 2020, the medical world was pretty much useless in the face of the disease. Not much medication and no vaccines were available. Who would have thought in those times that it would be possible to prevent COVID infection just through a nasal spray?
Researchers from Cornell University are now optimistic that in a few months, humanity will get to benefit from a nasal spray that can overcome COVID. Not only that it could act as a prevention method – but it also could treat people who have already become sick from the coronavirus, according to StudyFinds.org.
The molecule N-0385 represents the key
Researchers conducted laboratory tests on mice and concluded that the molecule known as N-0385 is the MVP of the match when it comes to both prevention and treatment of COVID.
Funds are still needed in order to start human trials.
Hector Aguilar-Carreno, who’s an associate professor of virology from the Department of Microbiology and Immunology in the College of Veterinary Medicine, explains as StudyFinds.org quotes:
There are very few, if any, small molecule antivirals that have been discovered that work prophylactically to prevent infection,
A TMPRSS2 Inhibitor ACTS as a pan-SARS-CoV-2 prophylactic and therapeutic.
The same expert says, according to the same source:
This is the first of its kind,
One advantage is that it works early in the infection, even after someone has already acquired the virus.
Researchers hope that in a maximum of six months, the nasal spray will receive approval from the Food and Drug Administration (FDA).
According to data provided by worldiometers.info, a total of over 486.5 million cases of COVID infections have been reported worldwide since the pandemic started. Unfortunately, the overall situation still doesn’t seem too good, as the BA.2 variant is now generating more and more infections with the coronavirus.